Bosh sahifaBSLN • SWX
add
Basilea Pharmaceutica AG Allschwil
Yopilish kursi
41,20 CHF
Kunlik diapazon
40,25 CHF - 41,20 CHF
Yillik diapazon
32,00 CHF - 47,95 CHF
Bozor kapitalizatsiyasi
530,08 mln CHF
Oʻrtacha hajm
29,06 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
SWX
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CHF) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 38,15 mln | -10,14% |
Joriy xarajat | 7,53 mln | -0,65% |
Sof foyda | 10,37 mln | -34,87% |
Sof foyda marjasi | 27,18 | -27,52% |
Har bir ulushga tushum | — | — |
EBITDA | 5,08 mln | -73,92% |
Amaldagi soliq stavkasi | -183,10% | — |
Balans
Jami aktivlari
Jami passivlari
| (CHF) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 62,96 mln | -28,22% |
Jami aktivlari | 188,66 mln | -17,98% |
Jami passivlari | 171,88 mln | -20,07% |
Umumiy kapital | 16,79 mln | — |
Tarqatilgan aksiyalar | 12,12 mln | — |
Narxi/balansdagi bahosi | 29,86 | — |
Aktivlardan daromad | 6,30% | — |
Kapitaldan daromad | 9,20% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CHF) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 10,37 mln | -34,87% |
Operatsiyalardan naqd pul | 8,96 mln | -18,04% |
Sarmoyadan naqd pul | 130,50 ming | 167,10% |
Moliyadan naqd pul | -6,57 mln | 23,07% |
Naqd pulning sof oʻzgarishi | 2,57 mln | 17,51% |
Boʻsh pul | 3,78 mln | -67,98% |
Haqida
Basilea Pharmaceutica is a biopharmaceutical company based in Allschwil near Basel, Switzerland. Basilea was spun off from F. Hoffmann-La Roche in 2000 and has been listed as an independent company on the Swiss stock exchange since March 2004. The company's subsidiary is Basilea Pharmaceutica International AG, Allschwil, which is also based in Allschwil, Switzerland, and in which the company's operating activities are bundled. Wikipedia
CEO
Tashkil etilgan
2000
Sayt
Xodimlar soni
156
